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Abstract 
Deletion 22q11.2 syndrome (Del22) (DiGeorge/Velo-Cardio-Facial syndrome) is 
characterized by congenital heart defect (CHD), palatal anomalies, facial 
dysmorphisms, neonatal hypocalcemia, immune deficit, speech and learning 
disabilities. CHD is present in 75% of patients with Del22. The most frequently seen 
cardiac malformations are “conotruncal” defects, including tetralogy of Fallot (TF), 
pulmonary atresia with ventricular septal defect (PA-VSD), truncus arteriosus (TA), 
interrupted aortic arch (IAA), and ventricular septal defect (VSD). The study of the 
specific “cardiac phenotype” in patients with Del22 shows that a particular cardiac 
anatomy can be identied in these subjects. In addition to CHD, various organ 
systems can be involved, so that a multidisciplinary approach is needed in the 
evaluation of patients with Del22. 
MeSH: Deletion 22q11, DiGeorge syndrome, Velo-Cardio-Facial syndrome, Heart 
defects, congenital 
 
Introduction 
DiGeorge and Velo-Cardio-facial syndromes are genetic conditions with overlapping 
features, including congenital heart defect (CHD), facial anomalies, hypoplastic 
thymus with immune deficit, palatal anomalies, neonatal hypocalcemia, speech and 
learning disabilities.1,3 Cytogenetic and molecular studies have demonstrated that 
microdeletion of chromosome 22q11.2 (del22) is detectable in the majority of patients 
with DiGeorge/Velo-cardio-facial syndrome.4,5 Del22 syndrome is considered to be 
developmentally related to neural crest anomalies, influencing the differentiation of 
the branchial arches.6,7 It is estimated that del22 syndrome occurs in 1 in 4000-6000 
live births, making this disorder a significant health concern in general population.8 
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Clinical features 
The variability in the clinical expression of del22 syndrome is extremely wide.9 
Classical features of del22 syndrome include CHD, velopharyngeal insufficiency or 
cleft palate, facial anomalies, speech and learning disabilities, neonatal 
hypocalcemia, and T-cell immune deficit. Nevertheless, the spectrum of anomalies 
associated with del22 is becoming wider and wider.2 Inter-individual variability in 
del22 phenotype is characteristic, since subjects with full-blown clinical expression of 
the syndrome as well as mildly affected individuals can be found. The main clinical 
features of Del22 syndrome and their occurrence in our series of 165 patients are 
listed in Table 1. 
 
Table 1 Main clinical features of Del22 syndrome and their occurrence in this series 
 
 
Facial anomalies 
Accurate phenotypical evaluation of patients with Del22 demonstrates that facial 
anomalies, severely or mildly expressed, are detectable in all subjects. Characteristic 
facial features include periorbital fulness, narrow upslanted palpebral fissures, 
prominent nose with large tip and hypoplastic nares, small mouth with everted upper 
lip and small dysmorphic ears (Figures 1,2). Many children, particularly in neonatal 
age, may have only a “subtle” facial phenotype. The experience of physicians caring 
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with children affected by del22 is fundamental in recognizing mild facial anomalies 
associated with the syndrome. 
 
Figure 1 Facial appearance of patient with Del22 syndrome 
 
 
Figure 2 Facial appearance of patient with Del22 syndrome 
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Congenital heart defects 
75% of patients with Del22 have symptomatic CHD.2 The most frequently seen 
cardiac malformations are “conotruncal” defects, including tetralogy of Fallot (TF), 
pulmonary atresia with ventricular septal defect (PA-VSD), truncus arteriosus (TA), 
and interrupted aortic arch (IAA).2,10–15 VSD, as well as asymptomatic aortic arch 
malformations are increasingly been diagnosed in patients with Del22 (Table 2).16 
 
Table 2 Cardiac anomalies in this series. 
 
 
The study of the specific “cardiac phenotype” in patients with Del22 shows that a 
particular cardiac anatomy can be identified.15 In fact, patients with conotruncal heart 
defect and Del22 have often additional CHDs as a distinctive recognizable pattern. 
Tetralogy of Fallot: Additional cardiac defects are found in the half of the patients with 
this TF and Del22.17,18 The associated cardiac defects include: 1) right or cervical 
aortic arch with or without aberrant left subclavian artery; 2) hypoplasia or absence of 
the infundibular septum; 3) absence of the pulmonary valve; 4) discontinuity and 
diffuse hypoplasia of the pulmonary arteries. 
Pulmonary atresia with ventricular septal defect: Considering the pattern of 
pulmonary blood supply, among children with pulmonary atresia with ventricular 
septal defect two major groups of patients can be recognized: 1) children with a 
single ductus arteriosus that usually presents confluent and well formed pulmonary 
arteries (also called tetralogy of Fallot with pulmonary atresia), and 2) children with 
major aortopulmonary collateral arteries (MAPCA) frequently associated with 
discontinuity, hypoplasia or absence of the central pulmonary arteries. In children 
with pulmonary atresia with ventricular septal defect and Del22 the pattern of 
pulmonary blood supply provided by the MAPCA is prevalent.19–22 Additionally, a high 
prevalence of right aortic arch and of discontinuity and defects of arborization of the 
pulmonary arteries can be found. 
 
 
Truncus arteriosus: Del22 is prevalent in patients with TA with nonconfluent 
pulmonary arteries (Type 3 of van Praagh), in which the right pulmonary artery arises 
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from the TA near to the truncal valve, and the left pulmonary artery is supplied by the 
ductus arteriosus.23–25 Additional CHDs to TA are: 1) interruption or right aortic arch; 
2) discontinuity, stenosis, or crossing of the pulmonary arteries; 3) severe dysplasia 
of the truncal valve; 4) origin of the TA from the right ventricle. 
Interrupted aortic arch: Del 22 is particularly common in patients with IAA type B.26–30 
In these cases the infundibular septum is often hypoplastic or absent and is deviated 
posteriorly and to the left; the VSD results in a subarterial position doubly committed 
with the pulmonary and aortic valves. 
Ventricular septal defect: The type of VSD in patients with Del22 is prevalently 
subarterial doubly committed.16,31 Right or cervical aortic arch may be associated. 
 
Palatal anomalies 
Two thirds of the patients with Del22 are found to have palatal anomalies, and the 
spectrum of malformations is wide.2,3,40 The majority have velopharyngeal 
insufficiency in the absence of cleft palate, but overt clefts, bifid uvula and cleft lip 
may also be present. Palatal function plays an important role in the development of 
speech. 
 
Immune deficit 
The immunodeficiency in Del22 syndrome is due to poor formation of thymic tissue 
and impaired production of T-cells. The most common immunologic abnormality is 
low number of T-cell, and functional T-cell deficiency is found in a minority of all 
patients.41 Nevertheless, the spectrum of immunocompromise in the Del22 patient 
population is broad. Children with Del22 have a significant risk of infection due to 
anatomical effects such as CHD and cleft palate. The additional risk associated with 
immunodeficiency may represent a critical factor in the management of these 
patients. Fortunately, the T-cell number usually increases by time and the cell 
function is not altered. Usually, patients with del22 are at most risk for repeated 
infections in the first years of life, but older children and adults do generally not have 
recurrent infections. 
 
Hypocalcemia 
Neonatal hypocalcemia is recognized in most of children with Del22.2 This symptom 
is related to hypoparathyroidism due to absence or underdevelopment of parathyroid 
glands, which leads to low blood calcium levels.42,43 Hypocalcemia may cause 
tremors, seizures, and arrhythmia. Calcium supplementation leads to normalization 
of blood calcium levels. The development of hypoparathyroidism later in life is rarer. 
 
Speech / Learning impairment 
Developmental delays can be present in children with del22, including delays in the 
motor, linguistic and cognitive domains.44,45 Delayed motor development is mainly 
attributed to the hypotonia present in more than half of the patients with del22. 
Psychomotor therapy is therefore recommended from an early age. Difficulties in 
expressive language are generally evident in preschooler children. This delayed 
speech development is prevalently due to the concomitance of velopharyngeal 
insufficiency and developmental delay. Speech difficulties related to velo-palatal 
abnormalities may become clearly manifest late, particularly when speech has fully 
developed. During childhood, the majority of the children has learning problems, 
especially in the area of reading comprehension, arithmetic and problem-solving. 
Common problems seen in these patients are impulsivity, distractibility, 
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perseveration, and hyperactivity. Several common behavioural and temperamental 
features have been observed in children and adolescents with del22, including a 
predisposition to show a withdrawn behavior, depression, anxiety and a tendency to 
engage in obsessive and/or compulsive behaviours. Therefore, good monitoring and 
follow up of the socio-emotional development is important in all ages. 
 
Skeletal anomalies 
Skeletal anomalies and deformations have been detected in patients with del22.46–48 
In the first reports, a variety of hand malformations and clubfoot have been 
described. Thereafter, scoliosis and vertebral maformations, including butterfly 
vertebrae and vertebral coronal cleft, have been added to the list. As characteristic 
diagnostic marker, most of del22 patients have long tapered fingers (Figure 3). 
 
Figure 3 Long tapering fingers characteristics of Del22 syndrome 
 
 
Asymmetric crying face 
Unilateral partial facial palsy due to hypoplasia of the depressor anguli oris muscle 
(DAOM) results in asymmetry of the lower lip, especially evident in smiling and 
crying. The eye on the affected side usually closes normally. DAOM can be detected 
in about 20% of neonates with del22.49 
 
Audiological anomalies 
Hearing impairment is documented in 60% of patients with del22.2,50 Hearing loss is 
conductive in the majority of the cases, probably related to chronic otitis media with 
effusion and upper respiratory tract infections. Nevertheless, congenital 
sensorineural deafness is also diagnosed in some cases. Audiological evaluation is 
recommended in Del22 children, in order to reduce the risk of speech deficit. 
 
MC Digilio, B Marino, R Capolino, and B Dallapiccola. Clinical manifestations of Deletion 22q11.2 
syndrome (DiGeorge/Velo-Cardio-Facial syndrome). Images Paediatr Cardiol. 2005 Apr-Jun; 7(2): 23–
34.  
 29 
Growth 
A specific pattern of growth is identifiable in patients with Del22.51 Weight deficiency 
is frequent in the first years of age, being prevalently related to feeding difficulties. 
The growth in weight improves with time leading to overweight and obesity in 
adolescence. On the contrary, short stature is present in a minority of the patients. In 
fact, adolescent patients have prevalently normal height, with a small group of 
patients showing a constitutional delay in height growth. 
 
Genetics 
In 1992, a microdeletion of chromosome 22 at the q11.2 band was reported.52 The 
critical region has been subsequently defined (Figure 4). 
 
Figure 4 The 22q11 critical region commonly deleted in DiGeorge/velocardiofacial 
patients 
 
 
The majority of the patients carry a common 3 Mb deletion, but smaller deletions 
have also been found. To date, the size of the deletion has not been correlated with 
the phenotypical expression of the syndrome. Fluorescent in situ hybridization (FISH) 
is used as genetic laboratory test for 22q11.2 microdeletion detection (Figure 5). 
At least 30 genes have been mapped in the typical deleted region. Among genes 
located in the “critical” chromosomal region, TUPLE1, UFD1L and TBX1 have been 
particularly studied.53–55 Although TBX1 mutations have been recently detected in 
rare patients with clinical features of DiGeorge/Velo-Cardio-Facial syndrome without 
an identifiable Del22,56 it remains unclear whether several genes must be 
haploinsufficient to cause a clinical phenotype or whether a single locus 
predominates. 
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Figure 5 Fluorescent in situ hybridization showing Del22 
 
Familial transmission 
The Del22 is a “de novo” occurrence in the family in most of the cases. Nevertheless, 
inheritance of the microdeletions from one of the parents is possible, the frequency 
varying from 6% to 28% in different series.2,9,57–59 The affected parent often 
demonstrates a milder phenotype. Various genetic and non-genetic factors, including 
modifier genes, mosaicism, unstable mutations, allelic variations chance and 
environmental interactions, can be hypothesized to be involved in variable clinical 
expression of the syndrome in the same family. 
 
Non-syndromic conotruncal heart defects 
Several observations suggesting that del22 could be associated with “non-
syndromic” CHDs can be found in the previous literature on this argument.32,33 
However, 80% of these patients, reported as apparently “isolated” CHD, had in fact 
extracardiac features fitting within the del22 syndrome phenotype. Other 
investigations have shown that Del22 is virtually never found in non-syndromic 
patients with conotruncal CHDs.34–38 In a personal series of 305 patients with true 
non-syndromic CHD, we detected only one deleted patient.14 Thus, we believe that, 
in clinical practice, genetic tests searching for del22 are not indicated in all patients 
with conotruncal CHDs, but only in subjects with clinical anomalies of del22 
syndrome. Classic or subtle facial anomalies are fundamental useful tools for 
selecting children who should be tested for Del22.14,39 In this regard, also patients 
with distinct anatomic conotruncal defect subtypes must be included.14,39 
 
Conclusions 
Clinical expression of Del22 syndrome can be extremely variable and the degree of 
various organ systems involved is wide. Early recognition of the deletion is important, 
so that the treatment of involved organ anomalies can be initiated, screening for 
associated malformations performed and prevention of neuropsychological problems 
provided. In fact, as occurrs in several multiple system clinical conditions, the care of 
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patients with Del 22 can be very complex. A multidisciplinary approach is 
fundamental to ensure that the patient will be able to attain his or her maximal 
potential. 
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